The Limited Times

Now you can see non-English news...

Covid-19: Germany will use the experimental treatment touted by Trump


The country will become the first in the European Union to offer this cocktail of “monoclonal” antibodies which costs 2,000 euros per dose.

Germany is innovating and will also pay a tidy sum.

The country will become the first in the European Union to use the experimental antibody-based treatment administered to Donald Trump against Covid-19, Health Minister Jens Spahn announced on Sunday.

"The government bought 200,000 doses for 400 million euros", he told the newspaper Bild am Sonntag, which represents 2000 euros per dose.

This cocktail of “monoclonal” antibodies will be used in university hospitals next week, said the minister, stressing that Germany was “the first country in the EU” to use it in the fight against the pandemic.

Jens Spahn did not quote the name of the manufacturer who would supply the drug, but confirmed that it was the same treatment as that given to Donald Trump in early October.

The latter, then President of the United States, had contracted the coronavirus and was briefly hospitalized.


Bamlanivimab, new hope against Covid-19

These synthetic antibodies "work like a passive vaccination", explained the German minister.

"Administering these antibodies during the initial stages of infection can help high-risk patients avoid a more serious course."

They mimic what the immune system does after infection with the coronavirus by blocking the tip of the virus that allows it to attach to and penetrate human cells.

Regeneron, Eli Lilly ...

Donald Trump had received the treatment developed by the American laboratory Regeneron, a combination of two antibodies known as REGN-COV2, even before it was authorized at the end of November by the American Medicines Agency (FDA).

The ex-president praised this treatment, saying that he had "cured" it.

The American company Eli Lilly has developed a similar treatment, authorized as of November 9.


Pfizer vaccine: five or six doses per vial?

The question that can change everything

Germany's order comes amid growing criticism in the EU about the slow pace of vaccination campaigns.

Vaccine makers Pfizer / BioNTech and AstraZeneca both announced smaller than expected deliveries in the near term to Europe due to production difficulties.

Morning essentials newsletter

A tour of the news to start the day

Subscribe to the newsletterAll newsletters

The German government has indicated that it still plans to be able to offer the vaccine to all Germans by the end of August.

Source: leparis

All life articles on 2021-01-24

Similar news:

You may like

Tech/Game 2021-02-23T20:31:22.335Z

Trends 24h

Life/Entertain 2021-07-29T21:47:59.299Z
Life/Entertain 2021-07-29T19:42:01.396Z


© Communities 2019 - Privacy